Modern healthcare systems produce endless amounts of data, but finding the right data to enhance your organization’s research and development activity can be a big challenge.
Our approach at Nashville Biosciences focuses on your use case: tailoring a multimodal dataset to your unique specifications to achieve an optimal return on your clinical, operational and financial investment.
Modern healthcare systems produce endless amounts of data, but finding the right data to enhance your organization’s research and development activity can be a big challenge.
Our approach focuses on your use case: tailoring a multimodal dataset to your unique specifications to achieve an optimal return on your clinical, operational and financial investment.
Advance novel discoveries and products with real-world data enabled for research and discovery.
Seamlessly integrate diverse data types to unlock the full spectrum of biological information.
Identify cohorts with a breadth of disease-specific features and years of longitudinal clinically relevant data.
Select patients from a diverse population relative to age, disease and other demographics.
Collaborate with our scientific and clinical experts to find the right data for your use case.
Accelerate speed to market with our flexible, customer-centric approach and proven commercial track record.
When patients visit Vanderbilt University Medical Center (VUMC), their clinical encounters are documented in VUMC’s electronic health record (EHR). NashBio’s Clinical Data is a synthetic derivative of this EHR, created to enable research and discovery, and is the backbone of our offerings.
Learn more
Precision medicine, an approach to patient care that is tailored to the individual, is an attainable goal. A key component of precision medicine is a patient’s genes and how their genes influence their risk of disease & progression and their response to treatment. NashBio’s data covers both the phenotypic and the genotypic patient data, enabling the interrogation of these interactions.
Learn more
Biological samples offer insight into the molecular processes at play in our cells and deepen our understanding of human disease. BioVU® is a collection of biosamples that are linked to patients’ electronic health records and scrubbed of all personal identifiers. Assays may be performed on these biosamples to generate new omic data linked to each patient’s phenome.
Learn more
Images are a powerful tool for diagnostic and interventional purposes. By nature, medical imaging is non to minimally invasive, and consequently is a preferred procedure when monitoring and when repeat acquisition are required. When these images are linked to a patient’s EHR, they enable the development of deep, longitudinal, multi-modal phenotypes.
Learn more
Care teams rely on real-time monitoring from electrocardiograms (ECGs), mechanical ventilators, electroencephalograms (EEGs) and other high frequency data streams to quickly detect changes in a patient’s health and guide decision making for safe and effective treatment plans.
Learn more
Large-scale association analyses are commonly performed to link phenotypic and genomic datasets. Study findings may elucidate new targets for drug discovery, expand existing drug labels or new populations that would benefit from a therapeutic. NashBio’s 90,000-subject MEGAEX + linked de-identified electronic health records dataset serves as the substrate for our association studies.
Learn more
When patients visit Vanderbilt University Medical Center (VUMC), their clinical encounters are documented in VUMC’s electronic health record (EHR). NashBio’s Clinical Data is a synthetic derivative of this EHR, created to enable research and discovery, and is the backbone of our offerings.
Learn more
Precision medicine, an approach to patient care that is tailored to the individual, is an attainable goal. A key component of precision medicine is a patient’s genes and how their genes influence their risk of disease & progression and their response to treatment. NashBio’s data covers both the phenotypic and the genotypic patient data, enabling the interrogation of these interactions.
Learn more
Biological samples offer insight into the molecular processes at play in our cells and deepen our understanding of human disease. BioVU® is a collection of biosamples that are linked to patients’ electronic health records and scrubbed of all personal identifiers. Assays may be performed on these biosamples to generate new omic data linked to each patient’s phenome.
Learn more
Images are a powerful tool for diagnostic and interventional purposes. By nature, medical imaging is non to minimally invasive, and consequently is a preferred procedure when monitoring and when repeat acquisition are required. When these images are linked to a patient’s EHR, they enable the development of deep, longitudinal, multi-modal phenotypes.
Learn more
Care teams rely on real-time monitoring from electrocardiograms (ECGs), mechanical ventilators, electroencephalograms (EEGs) and other high frequency data streams to quickly detect changes in a patient’s health and guide decision making for safe and effective treatment plans.
Learn more
Large-scale association analyses are commonly performed to link phenotypic and genomic datasets. Study findings may elucidate new targets for drug discovery, expand existing drug labels or new populations that would benefit from a therapeutic. NashBio’s 90,000-subject MEGAEX + linked de-identified electronic health records dataset serves as the substrate for our association studies.
Learn more
Acute pancreatitis has become increasingly prevalent across the world, affecting nearly 85,000 individuals annually. Patients with acute pancreatitis experience…
Nashville Biosciences recently worked with Pfizer’s Target Sciences and Technologies group to explore genetic targets for treating a serious metabolic disease with greatly increasing…
Nashville Biosciences recently worked with a clinical stage biotech to develop a synthetic control arm for its active single-arm clinical trial in a rare but…
Acute pancreatitis has become increasingly prevalent across the world, affecting nearly 85,000 individuals annually. Patients with acute pancreatitis experience…
Nashville Biosciences recently worked with Pfizer’s Target Sciences and Technologies group to explore genetic targets for treating a serious metabolic disease with greatly increasing…
NashBio was created to make unique, complex data from the patient’s healthcare journey easy to use. We provide curated datasets within the context of each individual patient’s journey, so you understand the full picture of each patient’s data and are able to put the data to work for your unique goals.
NashBio was created to make unique, complex data from the patient’s healthcare journey easy to use. We provide curated datasets within the context of each individual patient’s journey, so you understand the full picture of each patient’s data and are able to put the data to work for your unique goals.
de-identified unique subjects
unique DNA samples with 250K genotyped
average length of clinical data
peer-reviewed publications
AGD aims to accelerate the development of novel therapeutics through the use of large-scale genomics and the creation of a preeminent real-world genomic resource.
AGD aims to accelerate the development of novel therapeutics through the use of large-scale genomics and the creation of a preeminent real-world genomic resource.
3841 Green Hills Village Dr., Suite 200
Nashville, TN 37215-2691
4660 La Jolla Village Drive
Suites 100 & 200
San Diego, California 92122
3841 Green Hills Village Dr., Suite 200
Nashville, TN 37215-2691
4660 La Jolla Village Drive
Suites 100 & 200
San Diego, California 92122
(615) 208-5462
info@nashbio.com
© 2025 Nashville Biosciences, LLC. All Rights Reserved. | Leveraging Vanderbilt University Innovation
© 2025 Nashville Biosciences, LLC. All Rights Reserved. | Leveraging Vanderbilt University Innovation
